JimVanMeerten (61.49)

September 2010

1

Could Monsanto (MON) be in for a fall? Has it over promised and under performed? Monsanto is a leading global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. The combination of its herbicides, seeds and related genetic trait products provides growers with integrated solutions to more efficiently and cost effectively produce crops at higher yields, while controlling weeds, insects and diseases. Its base business, led by Roundup and coupled with the latest tools in biotechnology, genomics and molecular breeding.

First let me say that the stock has a great following on both Wall Street and the general investing public. Let's look at the facts. Deep discounting of prices by competitors and wold wide depressed demand in agricultural products have caused depressed sales and earnings figures.

Barchart has a 72% technical sell signal and the stock is trading below its 20, 50 and 100 day moving averages. The stocks recent price of 48.01 is well below its 50 day moving average of 56.39. The stock lost 14.02% in just the last 5 days alone. The 14 day Relative Strength Index is only 27.87% and tanking.

One technical note is that short interest is increasing and volume is falling. A bad short term sign.

At this time I'd sell present positions or place a short term short but be prepared to cover if the price trend reverses.

2

Exxon Mobil Corporation (XOM) is a big company with big profits and a big following. Their principal business is energy, involving exploration for, and production of, crude oil and natural gas, manufacturing of petroleum products and transportation and sale of crude oil, natural gas and petroleum products. XOM is a major manufacturer and marketer of basic petrochemicals, including olefins, aromatics, polyethylene and polypropylene plastics and a wide variety of specialty products. XOM is engaged in exploration for, and mining and sale of coal, copper and other minerals.

I look at XOM as a triple play. Since they purchased XTO, one of the largest natural gas companies they have a triple whammy in oil, natural gas and plastics. If natural gas prices recover and industries complete their planned conversions to NG some good profits could fall to the bottom line.

Buying XOM is almost like buying an energy commodity ETF but better. The stock came under my notice when it recently hit 10 new highs in the last 20 sessions and earned a 100% Barchart technical buy signal. This behemoth went up 5.42% in the last month and recently traded around 62.19 well above its 50 day moving average of 60.75. The stock has a 14 day Relative Strength Index that is 61.43% and still rising.

For a stock this big the Wall Street brokerage firms have some aggressive increases in sales and earnings projected. The analysts have 9 buy and 10 hold reports published and predict sales will increase 22.60% this year and 10.60% next year. The EPS projections are even better with projected increases of 43.10% for this year, 10.30% next year and a 5 year annual growth rate of 11.87% expected.

I like that short interest is shrinking. The smart money was shorting 98 million shares back on 5/14 and that has dropped to only 33 million shares recently. That's a good sign when short shares keep getting covered.

This big company has a big following and general investor interest is high. On Motley Fool the CAPS members vote 7,294 to 482 that the stock will beat the market and the All Stars agree 1,668 to 76. Articles on the stock were positive 26 to 3.

My thinking is that as the world economies recover they will consume more energy making XOM's world wide position in oil, natural gas and plastics a good place to be positioned.

My buy points are:1 - Great world wide placement in energy and plastic in a recovering economy [more]

Recs

1

I added Theravance Inc (THRX) to the Barchart Van Meerten New High portfolio. They are focused on the discovery, development and commercialization of small molecule medicines for unmet medical needs across a number of therapeutic areas including respiratory disease, bacterial infections, overactive bladder and gastrointestinal disorders.

The stock hit 19 new highs in the last 20 sessions with a 51.29% price increase last month alone. Barchart has a 96% buy signal. The stock trades around 19.41 far above its 50 day moving average of 15.24. The 14 day Relative Strength Index is 80.57% and rising.

The stock doesn't have a wide following but it is positive with the CAPS members on Motley Fool voting 64 to 29 that the stock will beat the market and the All Stars agree 25 to 11. Fool notes that the last 9 Wall Street columnists' articles have been positive.

The brokerage firms have 5 buy recommendations published based on a consensus of sales increases of 13.00% this year and 35.30% next year. The earnings per share are expected to increase 12.60% this year, 6.50% next year and maintain a 34.70% annual EPS growth rate for at least 5 years.

The major 3 criteria are met:1 - Recent and positive price momentum [more]

Recs

1

This morning I added Sanofi-Aventis (SNY) to the Barchart Van Meerten New High portfolio They are a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated health care solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of health care products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.

Two of the drugs they produce are two of the most widely marketed drugs on the planet. The A/H1N1 flu vaccine and Plavix. I can't watch an evening of TV without seeing several Plavix commercials. Since I had my flu shot my cravings for corn and mud baths are now under control.

The stock is on a recent climb with 19 new highs in 20 session for a 19.82% price gain last month. Barchart has a 96% buy signal with the stock trading around 33.95 above its 50 day high of 30.27. The stock has a 76.93% 14 day Relative Strength Index and is rising.

General investor sentiment is high with the CAPS members on Motley Fool voting 882 to 41 that the stock will beat the market and the All Stars are in agreement 329 to 11. The Wall Street columnists that Fool follows had 14 positive articles on the stock.

Their major markets of the US and Europe means they are marketing in an area of both public and private health care that can afford their products. With all the recent interest in flu vaccines and diabetes drugs this stock should be a winner.

1

Apple (AAPL) is a stock that everyone seems to have an opinion about. If there is anyone on the planet that hasn't heard of Apple the company designs, manufactures and markets personal computers and related personal computing and communicating solutions for sale primarily to education, creative, consumer, and business customers.

I once heard Mrs.Fields say she didn't sell cookies, she sold warm memories of your childhood and the smells coming from your Grandma's kitchen. To say Apple is a computer company also isn't enough. When I go to the mall and pass the Apple store the place is packed and everyone, young and old is standing in a line to get a hands on experience.

All other companies just produce lap tops, computers and PCs -- Apple produces MACs and I-Pods and all sort of devices with wonderful sounding names that you've just got to have before anyone else has one. Other companies are just the present; Apple has the mistique of being the future.

OMG have the Apple worms crawled in my ears and are now controlling my mind like they've done to all the other cult members? Is there any way I can plug my ears to the songs of the Apple sirens and write an honest and objective view of this stock?

Let's get the popular stuff out of the way. To say Apple has a following is an understatement. On Motley Fool the CAPS members vote 22,413 to 2,018 that the stock will beat the market and the All Stars are similarly in a trance by a vote of 4,787 to 236. Even the Wall Street columnists Fool follows have written positive articles 46 to 0.

The Wall Street brokerages are not immune to the hype. There are 43 firms with published recommendations and their analysts have 25 strong buy and 22 buy reports published. For you math buffs I know that doesn't sound right but several of the firms have the stock classified in multiple categories and have more than one analyst following it. The consensus estimates are very aggressive with sales expected to increase 73.60% this year and 24.70% next year. Earnings per share are expected to increase 59.10% this year, 21.90% next year and continue at a 20.19% annual rate for at least 5 years.

Even the old staid and very objective Value Line thinks the stock is a timely acquisition for your portfolio.

Let's step back and look at raw numbers using Barchart. I note that there are 12 of the 13 Barchart technical indicators on a buy signal for an overall 96% buy rating. The stock hit 19 new highs in the last 20 sessions including 5 in the last 5. Last month alone the price climbed 17.75% and recently traded at 288.62 well above its 50 day moving average of 258.20. The 14 day Relative Strength Index is 80.79% and rising.

For those of you who follow my blogs you know I try to be objective and not follow the crowd. Just because Citi is one of the most widely traded and reported stock has not swayed me into buying that dog. Here with Apple it looks like the real deal. Here's what its got: [more]

Recs

2

I've added Suburban Propane Partners, L.P. (SPH) to the Barchart Van Meerten New High portfolio. They are a publicly traded Delaware limited partnership engaged, through subsidiaries, in the retail and wholesale marketing of propane and related appliances and services. The Partnership believes it is the third largest retail marketer of propane in the United States. Suburban Propane Partners serves active residential, commercial, industrial and agricultural customers from customer service centers in over 40 states. The Partnership's operations are concentrated in the east and west coast regions of the United States.

This is not the propane company in Arlen, Texas and Hank doesn't work there. For those of you who don't live in the US propane users are a captive market. Propane is used for cooking and heating in homes plus many industrial users that are usually rural and far from the natural gas pipelines as well as in many portable appliances.

The stock is on a move with a 96% overall Barchart buy signal. The stock hit new highs in 19 of the last 20 sessions and has moved up 11.21% in the last month. The stock has a 14 day Relative Strength index of 76.01% and recently traded at 53.72 well above its 50 day moving average of 49.71.

This is basically a utility stock and should recover nicely. Wall Street brokerages have 5 buy reports published based on projections of increased sales and earnings for the next 5 years and a safe dividend coverage.

The general investor has noticed this stock and on Motley Fool the CAPS members voted 252 to 15 that the stock will out perform the market and the All Stars agree 97 to 3.

If you'd like a stock that is enjoying capital appreciation and still pays a 6.8% dividend while you wait this could be the stock for you.

4

I added ProShares Ultra Silver ETF (AGQ) to the Van Meerten New High portfolio, The ETF seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of silver bullion as measured by the U.S. Dollar fixing price for delivery in London. This is a pure price play on the prices of precious metals and will be sold if it doesn't pan out.

If I look at the general sentiment as measured on Motley Fool the CAPS members think the ETF will outperform the market by a vote of 92 to 51 with the All Stars in similar agreement with a vote of 36 to 25. Not an overwhelming vote but positive none the less.

I'm really looking at the technicals over on Barchart. The 13 technical indicators give a 96% buysignal with the ETF moving up in 17 of the last 20 sessions. The ETF recently traded at 74.78 well above its 50 day moving average of 62.91. The price has moved up 30.10% in the last month and has a Relative Strength Index of 72.06% and rising.

1

I added Broadridge Financial Solutions (BR) to the Barchart Van Meerten New High portfolio. They are a leading global provider of technology-based outsourcing solutions to the financial services industry. Their integrated systems and services include investor communication, securities processing, and clearing and outsourcing solutions. Broadridge offers a broad, integrated suite of innovative global solutions across the investment lifecycle and provides a wide range of cost-effective and scalable solutions to the financial industry. Their systems help reduce the need for clients to make significant capital investments in operations infrastructure, thereby allowing them to increase their focus on core business activities.

Although Wall Street brokerages only have 1 buy recommendation published it is based on an estimate of an increase in sales and in earnings per share of 10.00% annually for the next 5 years.

The stock has recent upward price movement with 18 new highs in the last 20 sessions including 5 of the last 5. Barchart has an overall 96% technical buy signalwith the stock trading around 23.18 well above its 50 day moving average of 20.97. The price appreciated 15.54% last month with a 14 day Relative Strength Index of 79.27%.

What drew me to the stock was the very positive general investor sentiment with the CAPS members on Motley Fool betting the stock will beat the market by a vote of 220 to 9 with the All Stars even more positive with a vote of 83 to 0. The Wall Street columnists Fool follows have written 5 positive articles about it.

3

I added Verizon Communications (VZ) to the Barchart Van Meerten New High portfolio. The company was formed by the merger of Bell Atlantic and GTE and is one of the world's leading providers of high-growth communications services. Verizon companies are the largest providers of wire line and wireless communications in the United States. Verizon is also the world's largest provider of print and on-line directory information.

At the present time the company is on an acquisition and consolidation plan that should eventually mean so -- I can't believe I'm using this term " synergism " t0 their far flung operations. Fewer people, less redundancy hopefully more sales and earnings per share.

Wall Street brokerages have 13 buy reports published and look for increased sales and earnings and over time a 5.96% annual growth rate for at least 5 years.

This is one of the most widely followed stocks by the general investing public and over on Motley Fool 4067 CAPS members voted the stock will beat the market to only 262 that think it won't. The more experienced All Stars voted 1050 to 37. Fool notes that of the Wall Street columnists they follow all 32 of the articles have been positive.

The stock has recent price momentum with 18 new highs in the last 20 session including all of the last 5. Barchart has a 100% technical buy signalwith the stock trading at 31.19 well above its recent 50 day moving average of 29.03. The stock appreciated 8.89% last month and has a 14 day Relative Strength Index of 78.54% and rising.

This stock has:

Wall Street brokerages looking for increased sales and earnings A very wide and positive investor following Recent price movement with all technical indicators on Barchart very positive.

3

The market action this week was stronger and gave me some hope for the future. We will use our 3 yardsticks because no single one tells it all. All the data comes from Barchart. Let's see where we stand.

1

Tanzanian Royalty Exploration Inc. (TRE)was added to the Barchart Van Meerten Speculative portfolio this morning. TRE is a mineral resource company whose business strategy is to acquire royalty interests of future gold positions in both pre-production and production.

The stock rated a 96% Barchart buy signaland hit 16 new highs in the last 20 sessions including 5 in the last 5. Price appreciation was 28.41% last month and the stock recently traded at 6.98 well above its 50 day moving average of 5.49. The 14 day Relative Strength Index was 98.04%

The general investing public is still high on gold stocks and on Motley Fool the Caps members voted 141 to 22 that the stock will beat the market with the All Stars also high by a vote of 70 to 7.

1

Terremark Worldwide Inc. (TMRK)was added to the Barchart Van Meerten New High portfolio this morning. TMRK is a global leader in providing Internet infrastructure and managed services. Terremark is the owner and operator of the NAP of the Americas, the premier Network Access Point in the world and the model for TerreNAP Data Centers the company intends to deploy in emerging markets.

Wall Street brokerage firms love this company and have published 11 buy recommendations to their clients. Analysts feel sales will grow by 18.80% this year and 19.00% next year. Earnings per share are expected to have annual increases of 21.25% for at least 5 years.

The stock has current price momentum and increased by 30.29% in just the last month. Barchart gave the stock an over-all 96% buy rating. The stock hit 17 new highs in the last 20 sessions including 5 in the last 5. The stock has a 14 day Relative Strength index of 98.33% and recently traded at 10.41 well above its 50 day moving average of 8.52.

The general investing public likes this stock too with the CAPS members on Motley Fool voting 78 to 22 that the stock will beat the market with the All Stars in agreement 28 to 12. Fool notes that of the Wall Street journalists they follow all of the last 13 articles about the company have been positive.

The stock deserves you attention because:

1 - Recent upward price momentum in more than 50% of the latest trading sessions [more]

Recs

1

I added Keegan Resources Inc. (KGN) to the Barchart Van Meerten Speculative portfolio this morning. KGN is a well-financed junior gold company with two premier gold assets in Ghana, West Africa, within one of the world's most prolific gold regions. KGN has successfully identified a significant gold deposit at its Esaase property which is currently being expanded with mineralization open in all directions. KGN's second project, the Asumura gold property, is located 65 km south of the 18+ M ounce Ahafo mine along one of Ghana's three major deposit hosting structures.

As with all commodity stocks we will consider this a technical momentum play and will sell if the upward price momentum is not sustained.

Only one Wall Street analyst is following the stock but he has a Strong Buy recommendation distributed to his clients.

KGN came up on my radar when I was using my Barchart new high screener to find stocks hitting the most frequent new highs. This one hit 14 new highs in 20 sessions including 5 in all of the last 5 sessions. The price increased 23.39% in the last month and is trading above its 20, 50 and 100 day moving average. The stock recently traded at 6.88 well above its 50 day moving average of 5.65. The 14 day Relative Strength Index is 83.07% and rising.

Even though only on Wall Street analysts is following the stock the general investing public in positive on this one. Over on Motley Fool the CAPS members voted 60 to 13 that the stock will beat the market with the All Stars in agreement 31 to 4.

Gold is where its at in this current market so if you are not over weighted in gold consider:

1

I added the Internet Capital Group (ICGE)to the Barchart Van Meerten Speculativeportfolio this morning. ICGE is an Internet holding company actively engaged in business-to-business e-commerce -- B2B e-commerce -- through a network of Partner Companies. It provides operational assistance, capital support, expertise, and a strategic network of business relationships intended to maximize the long-term market potential of business-to-business e-commerce Partner Companies.

The capital structure is innovative. They own a major investing interests in 13 different B2B e-commerce companies then help them through both funding and management assistance. A little bit venture capital - a little bit holding company. I like this.

Wall Street brokerages like it to with 4 Strong Buy recommendations distributed to their clients based on projections of increases in sales of 24.30% this year and 9.00% next year. The consensus is that earnings will increase 116.70% this year and continue at an annual rate of 15.00% for the next 5 years.

There is very good price momentum at the present time. Barchart has an 80% buy signal. The stock is trading above its 20, 50 & 100 day moving averages and recently traded at 9.79 well above its 50 day moving average of 8.56. The stock hit 14 new highs in the last 20 trading sessions and increased by 23.13% in the last month. The 14 day Relative Strength Index is at 68.52% and rising.

The general investing public as measured on Motley Fool has faith in the stock and voted 49 to 12 that the stock will beat the market with their All Stars in agreement 13 to 1.

2

This morning I deleted Radcom (RDCM) from the Barchart Van Meerten New High portfolio after an complete and unexplained price collapse. The stock dropped 31% in the last 2 sessions, Capital preservation is paramount in this fund so I'm not going to go against the numbers. [more]

Recs

2

This morning I added LJ International Inc.(JADE) to the Barchart Van Meerten Speculative portfolio. JADE together with its subsidiaries, engages in the design, manufacture, marketing, and sale of precious and color gemstones, and diamond jewelry. The company offers colored jewelry; and pieces set in yellow gold, white gold, platinum, or sterling silver and adorned with colored stones, diamonds, pearls, and precious stones. Its product line includes earrings, necklaces, pendants, rings, and bracelets. The company distributes its products to fine jewelers, national jewelry chains, department stores, and discount chain stores in North America. It also involves in the retail of jewelry through the ENZO brand in the Asia Pacific region with 95 company operated ENZO stores in the People's Republic of China, Hong Kong, and Macau. In addition, it owns commercial and residential properties in Hong Kong, which are held primarily for lease. As the world-wide economy recovers the jewelry business should recover also. They appear to be positioned with the right products in the right markets.

Barchart has a 96% technical buy signalwith recent price appreciation of 22.03% in the last month. JADE hit 15 new highs in the last 20 sessions including 5 of the last 5. The 14 day Relative Strength Index is 90.77% and the stock recently traded at 3.59 well above its 50 day moving average of 2.96.

Although Wall Street brokerages are not yet following this stock the general investing public on Motley Fool voted 227 to 6 that the stock will beat the market including the All Stars with a vote of 41 to 0.

1

This morning I added the iShares MSCI All Peru Capped Index Fund (EPU) to the Barchart Ban Meerten New High portfolio. EPU seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI All Peru Capped Index . The Index is a free float- adjusted market capitalization index designed to measure the performance of the "Broad Peru Equity Universe" MSCI by identifying Peruvian equity securities that are classified in Peru according to the MSCI Global Investable Market Indices Methodology as well as securities of companies that are headquartered in Peru and have the majority of their operations based in Peru.

1

This morning I added Clearwire (CLWR)to the Barchart Van Meerten Speculative portfolio. CLWR is a provider of simple, portable and reliable wireless high-speed Internet service. Clearwire customers connect to the Internet using licensed spectrum, thus eliminating the confines of traditional cable or phone lines. At the present time the company has 1 million customers and in a trend setter in the 4G WiMax technology.

Wall Street brokerage analysts have 5 buy recommendations out based on fantastic sales projections of an increase of 124.60% this year and 145.50% next year. Although operating at a loss at the present time the company should make a profit if their present sales goal are met.

Barchart has a 100% short term buy signaland the stock has appreciated 15.72% in the last month. The price hit 12 new highs in the last 20 sessions and has a 14 day Relative Strength Index that is 65.87% and on the rise. It recently traded at 7.50 which is above its 50 day moving average of 6.74.

The general investor has followed the stock and the CAPS members on Motley Fool think the stock will out perform the market by a vote of 497 to 76 with the All Stars in step 138 to 13.

1

This morning we added the Internet Infrastructure Holder (IIH) to the Barchart Van Meerten Speculative portfolio. The trust currently holds shares of common stock issued by a group of specified companies that were, at the time of the initial offering, generally considered to be involved in various aspects of the Internet infrastructure segment of the Internet industry. The Internet infrastructure segment of the Internet industry consists of companies that, among other things, provide software and related services, which allow Internet companies to better manage their Web sites and improve online communications.

At the latest report the trust had 8 positions of which 3 positions VeriSign (VRSN)-51%, Akami (AKAM) - 29% and Open Text (OTEX)- 10% accounted for 90% of its holdings. The portfolio has 51% in software and 49% in telecom sectors.

Barchart has a 96% buy signal. The trust has appreciated 8.50% in the last month by hitting 14 new highs in the last 20 sessions. The 14 day Relative Strength Index is 67.88% and on the rise. The price was recently 3.70 well above its 50 day moving average of 3.38.

The trust has a positive investor following with CAPS members on Motley Fool voting 43 to 3 that the trust will beat the market with the All Stars in agreement 14 to 1.

2

I'm adding RightNow Technologies (RNOW) to the Barchart Van Meerten New High portfolio. RNOW provides on-demand software solutions designed to optimize customer service operations for businesses of all sizes. Their comprehensive customer service solution features a self-learning knowledgebase that is designed to seamlessly support multiple communications channels including web, interactive voice, email, chat, telephone and proactive outbound email communications. Sounds like a product line that is more of a necessity than a luxury in today's competitive environment,

Wall Street analysts are high on this stock with 11 buy recommendations distributed to their clients. They project double digit increases in sales of 16.60% this year and 15.40% next year. They estimate the company will be profitable with an increase in earnings per share of 10.30% this year, 53.50% next year and continue for a 5 year annual EPS growth of 26.50%.

Barchart has a 100% overall technical buy rating based on buy signals from all 13 of their indicators. The stock appreciated 16.14% last month logging 15 new highs in the last 20 trading sessions. The 14 day Relative Strength Index is 75.00% and rising. The stock recently traded at 18.56 well above its 50 day moving average of 16.13.

Investor sentiment as measured on Motley Fool is positive with the CAPS members voting 81 to 21 that the stock will beat the market with the All Stars in agreement 24 to 8. Fool notes that of the Wall Street columnists they follow the last 10 articles have been positive.

2

Those of you who follow my blogs know that I am not an advocate of those that try to predict the future and where the market is headed. I let the numbers tell me what to do. I've got a little butterfly in my stomach and I want your opinions.

Let's use some common sense. You normally buy bonds for capital appreciation when yields are coming down because bond prices then go up. The other factor in the equation is: " Can the underlying debtor pay interest and principal payments when due".

Bond prices and in particular bond funds and ETFs have been enjoying price appreciation that have made them very attractive additions to your portfolios. I've been buying them too because the numbers have been positive.

Here are my concerns:1 - Bond yields are about as low as they can get so the upside price appreciation seems to have peaked [more]

Recs

1

I added Radcom (RDCM)to the Barchart Van Meerten New High portfolio purely for technical reasons The company designs, manufactures, markets and supports innovative, high performance internet working test and analysis equipment for data communications networks. Their products are used in the development and manufacturing of network equipment, the installation of networks, and the ongoing maintenance of operational networks. This stock has recently been mentioned as an M&A candidate so we need to closely monitor the price action if that's what's driving the price. If the company isn't acquired the price could soon drop. Because the stock moves so fast a stop loss is advised.

Barchart has a 100% technical buyrating on this stock. The price has appreciated 73.51% in the last month and it hit 14 new highs in the last 20 trading sessions. The stocks 14 day Relative Strength is 98.70% and seems steady. The stock recently traded at 11.68 well above its 50 day moving average of 6.78.

1

One of the advantages of buying stocks that are beginning to hit new highs and show upward price movements is that you will find that a good number of your positions are merger and acquisition targets. Prices do move up just before the acquisition news is released.

Last Friday we bought ZymoGentics (ZGEN) in the Barchart Van Meerten Speculative portfolio for an average cost of 5.48 a share and on Tuesday after the markets closedBristol-Myers (BYM)made a 9.75 bid for the stock. This morning we closed out our position at an average price of 9.71 for a profit of 77% during our 2 trading day holding period,

Some of you are probably wondering why I don't stick it out to see if a higher bid comes in but I find that a bird in the hand is worth two in the bush. I'll take my profits and reinvest into a new stock.

2

Last week things just weren't very solid. During the week there was still a lot of chatter about a double dip recession, the Hidenburg Effect and an impending bond bubble. Luckily the market didn't listen. Off with their talking heads! Let's look at our 3 yardsticks and see what really happened. We use 3 because no single yardstick works all the time. Barchart supplied tha data.

Value Line Index-- Contains 1700 stocks so it's much broader that the S&P 500 or very narrow Dow 30 -- Things looked good [more]

Recs

1

Protalix Biotherapeutics (PLX) was added to the Barchart Van Meerten Specualtive portfolio this morning. They are engaged in the provision of practice management services to the Affiliated Practices pursuant to long-term Administrative Services Agreements with separately organized affiliated professional associations. Under the Administrative Services Agreements, they have control over all non-orthodontic functions of the PA Contractors, including administrative, management, billing and support functions. Dentists have a reputation of being poor business managers, so they need all the help they can get.

The fundamentals of this stock are very hard to believe. 7 Wall Street brokerage firms have buy recommendations published based on their consensus estimates that sales will increase 1647.40% this year and 542.00% next year. Please - these are their estimates not mine. They believe earnings will increase 26.80% this year, 33.30% next year and continue at an annual rate of 25.00% for the next 5 years.

The general investing public is sceptical of these projections and on Motley Fool the CAPS members are split by a vote of 110 to 79 that the stock will beat the market and the All Stars are evenly split 29 to 29.

I'm, going with the recent price action of 12 new highs in the last 20 sessions for a price appreciation of 15.85% last month. All 13 of Barchart's technical indicatorssignal buy and the 14 day Relative Strength Index is 73.84% and rising. The stock traded at 7.98 recently above it's 50 day moving average of 6.76.

2

ZymoGenetics (ZGEN)was added to the Barchart Van Meerten Speculative portfolio this morning. They are an independent biopharmaceutical company focused on the discovery, development and commercialization of therapeutic proteins for the prevention or treatment of human diseases. They have also developed drugs and proteins that are used both during surgery and in post-op recovery to control bleeding and infection.

Wall Street brokerages have 6 buy and 3 hold recommendations based on projected increases of 15.80% in sales and 71.00% in earnings this year.

The general investing public as measured on Motley Fool thinks the stock will beat the market by a vote of 146 to 28 with the All Stars also voting 48 to 11.

I look for this to be a short term technical play. The price has appreciated 31.77% this month on 15 new highs in 20 sessions including 4 of the last 5. Barchart has 11 of 13 technical indicators positive giving an 80% buy signal. The 14 day Relative Strength index is 71.67% and rising. The stock recently traded at 5.41 will above its 50 day moving average of 4.43.

3

This morning I added Pre-Paid Legal Services (PPD)to the Barchart Van Meerten New High portfolio. They underwrite and market legal service plans which provide for or reimburse a portion of legal fees incurred by members in connection with specified matters. At the present time they have over $1,500,000+ members many of who pay a monthly fee though an employee benefit deduction.

This is mainly a technical play because only minor growth in sales is expected but favorable savings in billing rate negotiations might mean a 31.00% increase in earnings.

Barchart has a 100% technical buy signal, The price has appreciated 15.58% in the past 20 trading sessions with 14 new highs. The 14 day Relative Strength Index is 73.45% and rising. The stock recently traded at 58.01 well above its 50 day moving average of 49.77.

Even though only one Wall Steed brokerage analyst follows this stock the CAPS members on Motley Fool have heard about it and vote 196 to 67 that the stock will beat the market including the All Stars who vote 55 to 27. Fool notes that all 4 articles written by the Wall Street columnists they follow have been positive.

5

This morning I added RF Micro Devices (RFMD) to the Barchart Van Meerten Speculative portfolio. The company is a global leader in the design and manufacture of high-performance radio systems and solutions for applications that drive mobile communications. RFMD's power amplifiers, transmit modules, cellular transceivers and system-on-chip solutions enable worldwide mobility, provide enhanced connectivity and support advanced functionality in current and next-generation mobile handsets, cellular base stations, wireless local area networks, wireless personal area networks and global positioning systems. Recognized for its diverse portfolio of state-of-the-art semiconductor technologies and vast RF systems expertise, RFMD is a preferred supplier enabling the world's leading mobile device manufacturers to deliver advanced wireless capabilities that satisfy current and future market demands.

The cell phone industry is projected to increase year over year sales by 10% and RFMD supplies parts that are included in over half of all cell phones sold. This year they experienced a 70% increase is sales of their 3G hardware and they are deeply in development of their 4G product line.

Wall Street brokerages are high on this stock and have 13 buy recommendations distributed to their clients. Sales are projected to increase by 11.40% this year and 5.60% next year. Earnings are estimated to increase by 26.00% this year, 7.90% next year and continue at an annual rate of 15.00% for at least 5 years.

Technically the stock is on the move. The stock hit 12 new highs in the last 20 session and Barchart's technical indicatorshave 11 out of 13 buy signals for an 80% short term buy rating. The 14 day Relative Strength Index is 66.01% and rising. The price has appreciated by 20.83% in the last month and recently traded at 5.20 well above its 50 day moving average of 4.34.

The regular investor has discovered this stock and investor sentiment as measured by the CAPS members on Motley Fool vote 667 to 38 that the stock will beat the market with the All Stars voting 145 to 3. Fool notes that of the Wall Street columnists they follow 14 of the last 15 articles have been positive.

Points you should consider are:

1 - Wall Street buy reports to clients based on projections of increases in sales and earnings [more]

Recs

1

This morning I added PowerShares DB Gold Fund (DGP) to the Barchart Van Meerten New High portfolio purely for technical reasons. The ETF is based on the Deutsche Bank Liquid Commodity Index - Optimum Yield Gold Excess Return and managed by DB Commodity Services LLC. The Index is a rules-based index composed of futures contracts on gold and is intended to reflect the performance of gold. Again this is purely for technical reasons. The points I considered are:

1 - 14 new highs in the last 20 trading sessions including 4 of the last 5 [more]

They are a fully integrated company from the mining of bauxite at 8 different mines, to smelting and refining of the aluminum at 8 different refineries and smelters to actually shipping to the ultimate user. They are responsible of 17% of the world's total production of aluminum with over 7,000 employees scattered over Australia, the US, Guinea, Suriname, Jamaica, Brasil and Spain. As the economy recovers there should be a great need for aluminum.

The stock has recent and very positive price momentum. Barchart has a 96% buy signal based on buys on 12 of it's 13 technical indicators. The stock rose 17.08% last month with 11 new highs in the last 20 trading sessions. The Relative Strength Index is 63.75% and rising. The recent price of 6.52 is well above it's 50 day moving average of 5.72%.

Wall Street has yet to discover this stock but the only analyst following the stock has a buy recommendation published based on his estimate that sales will rise 16.70% next year. He also forecasts a 163.60% increase in EPS this year and a 5 year annual compounded EPS growth of 15.80% .

Even though Wall Street hasn't discovered this stock the general investing public has. On Motley Fool the CAPS members vote 240 to 10 that the stock will beat the market and the All Stars agree 104 to 3.

1

This morning I added NetSuite (N)to the Barchart Van Meerten New High portfolio. The company is a leading provider of on-demand, integrated business management software for growing and mid-size businesses. With thousands of customers globally using NetSuite's online products and professional services, companies are enabled to manage all key business operations in a single hosted system, including: customer relationship management; order fulfillment; inventory; accounting and finance, product assembly; e-commerce; Web site management; and employee productivity.

As the economy recovers new small and mid-sized start-ups will be buying business management software and existing businesses will be upgrading their software to be current and competitive. Businesses don't have time or the patience to deal with multiple vendors. They look for one stop shopping so NetSuite has a product line and a delivery system they might appreciate. What are the numbers on this stock?

There are 21 Wall Street Brokerages with published recommendations to their clients and 20 of them rate the stock as hold or better based on projections of double digit increases in sales and earnings. Sales are estimated to increase 13.90% this year and 16.60% next year. If their projections on earnings can be believed they look for increase in EPS of 140.00% this year, 83.30% next year and 27.00% annually for the next 5 years. Great numbers.

General investor awareness and sentiment as measured on Motley Fool is good. The CAPS members think the stock will out perform the market by a vote of 148 to 53 with the All Stars in step 33 to 9.

I really like the current price momentum. The stock has appreciated 32.28% in the last month by hitting 13 new highs in the last 2o trading session including all 5 of the last 5. Barchart's 13 technical indicators have 12 buy signals and the stock's 14 day Relative Strength Index is 72.34% and rising. It traded recently at 19.63 well above it's 50 day moving average of 15.47.